Renovacor is a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and related diseases. The company’s lead program in BAG3-associated dilated cardiomyopathy (DCM) uses gene transfer technology to address the monogenic cause of this severe form of heart failure. Renovacor’s vision is to bring life-changing therapies to patients living with serious genetic cardiovascular and related diseases, by developing medicines that target the underlying cause of disease and provide a transformative benefit and significant improvement to quality of life.
| Website | https://renovacor.com/ |
| Employees | 8 (6 on RocketReach) |
| Founded | 2019 |
| Phone | +1 202-628-6777 |
| Technologies |
JavaScript
,
HTML
,
PHP
+17 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Precision Medicine, Novel Therapies, Cardiovascular Research, Biotechnology, Targeted Therapies, Heart Disease Treatment, Advanced Therapies, Therapeutic Innovation, Biotech Research, Innovative Therapies, Pharmaceutical Research, Clinical Stage Biopharma |
| Competitors | Intellia Therapeutics, Inc., CRISPR Therapeutics, Editas Medicine, Moderna Therapeutics, bluebird bio, Beam Therapeutics, Verve Therapeutics, Base Genomics, Precision BioSciences, Inc., Agenus +34 more (view full list) |
Looking for a particular Renovacor employee's phone or email?
Renovacor Questions
Olga Baboshina is the Director of Regulatory Affairs-CMC of Renovacor.
6 people are employed at Renovacor.
Top Renovacor Employees
-
Olga Baboshina
Director of Regulatory Affairs-CMC at Renovacor
Lansdale, PA, US14 -
52
-
Brandi A
Senior Scientist at Renovacor
Washington, DC, US -
Matt Killeen
Chief Scientific Officer at Renovacor
San Francisco, California, United States1 -
Leandro Toqueiro
Empresário at Renovacor
Suzano, SP, BR
Related Companies
